Travel Vaccines Global Market Report 2025

Description

Travel vaccines are immunizations designed to protect against diseases prevalent in either the country of origin or the destination. Their purpose is to ensure the well-being of travelers and prevent the transmission of diseases within and between nations.

The primary travel vaccines targeting various diseases include hepatitis A, diphtheria, pertussis, and tetanus (DPT), yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, and others. Hepatitis A is caused by the hepatitis A virus (HAV), leading to liver inflammation. These vaccines are available as mono vaccines or combination vaccines and can be booked through online and in-person channels for domestic travel, as well as through outbound travel applications.

The travel vaccine market research report is one of a series of new reports from The Business Research Company that provides travel vaccine market statistics, including the travel vaccine industry global market size, regional shares, competitors with a travel vaccine market share, detailed travel vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the travel vaccine industry. This travel vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The travel vaccines market size has grown strongly in recent years. It will grow from $4.73 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increased international travel, government initiatives for travel health, globalization of diseases, growing awareness among travelers, and expansion of the travel and tourism industry

The travel vaccines market size is expected to see strong growth in the next few years. It will grow to $7.49 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to the increasing frequency of business travel, emerging infectious disease threats, government regulations and entry requirements, rising demand for exotic destinations, and collaboration between governments and pharmaceutical companies. Major trends in the forecast period include tailored vaccination strategies, expansion of the market to non-endemic regions, adoption of digital health technologies, regulatory support, and streamlined approvals, innovative developments.

The anticipated surge in travel and tourism is poised to drive the expansion of the travel vaccine market in the future. Travel and tourism encompass the movement of people and vehicles across various distant geographic areas, including trains, boats, airplanes, and other modes of transportation. Travel vaccines play a crucial role in ensuring the safety and health of tourists and travelers during their journeys abroad. As of January 2023, the United Nations World Tourism Organization (UNWTO) reported that over 900 million tourists ventured abroad in 2022, marking a twofold increase from the previous year and a substantial 63% rise from pre-pandemic levels. This surge in travel and tourism is a significant factor propelling the growth of the travel vaccine market.

The growth of the travel vaccine market is being driven by the increase in healthcare spending. Healthcare spending refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. This spending includes investments in travel vaccines as a preventive measure, which helps reduce the economic burden associated with treating travel-related diseases. Travel vaccines play a vital role in public health by minimizing the risk of infectious diseases during international travel, thereby avoiding costs related to medical treatment, hospitalization, and potential outbreaks upon return. For example, in September 2024, statistics published by Cross River Therapy, a US-based provider of ABA therapy services, indicated that the U.S. pharmaceutical industry generated $550 billion in revenue. In 2021, Americans spent $576.9 billion on medicine, with projected spending expected to rise to between $605 and $635 billion by 2025. Therefore, the increase in healthcare spending is propelling the growth of the travel vaccine market moving forward.

Product innovation stands out as a prominent trend gaining traction in the travel vaccine market, with major companies actively pursuing the development of innovative vaccines to strengthen their market positions. For example, in August 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, received approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003) from the Indonesia National Agency for Drug and Food Control. QDENGA, designed for the prevention of dengue sickness in individuals aged six to 45, demonstrated sustained overall protection against dengue sickness and hospitalization three years after immunization, regardless of prior exposure to the disease.

Major companies operating in the travel vaccine market are developing innovative vaccines to provide active immunization to prevent Hepatitis A common concern for travelers. A travel vaccine is a vaccine specifically designed to protect individuals from infectious diseases that are prevalent in certain regions or countries, often recommended for travelers visiting those areas. For instance, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology company, launched Havisure, India's first indigenously developed Hepatitis A vaccine. Havisure is anticipated to be instrumental in providing protection against the Hepatitis A virus, which mainly impacts the liver. This vaccine is effective in preventing the disease and is advised for children as part of routine immunization. Additionally, it is recommended for individuals at risk of exposure or those traveling to areas with high rates of hepatitis A.

In May 2023, Bavarian Nordic, a US-based biopharmaceutical company, acquired Emergent BioSolutions' travel vaccine portfolio for an undisclosed amount. This strategic acquisition includes two commercially available vaccines-Vivotif for preventing typhoid fever and Vaxchora for cholera prevention-as well as a Phase 3 vaccine candidate targeting the prevention of the Chikungunya virus. The deal also encompasses R&D facilities in the US, a Swiss biologics production facility, and EU and US commercial operations with a specialized salesforce. Emergent BioSolutions, a US-based biotechnology firm, specialized in manufacturing devices, vaccines, and therapeutics, with its travel vaccine division being part of the acquisition.

Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the travel vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The travel vaccine market consists of sales of vaccines for diseases such as Japanese encephalitis, tick-borne encephalitis, and tuberculosis (TB). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Travel Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on travel vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for travel vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The travel vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease: Hepatitis A; Diphtheria, Pertussis, And Tetanus (DPT); Yellow Fever; Typhoid; Hepatitis B; Measles And Mumps; Rabies; Meningococcal; Other Diseases;
2) By Composition: Mono Vaccines; Combination Vaccines
3) By Booking Channel: Online Booking; In-Person Booking
4) By Application: Domestic Travel; Outbound Travel
Subsegments:
1) By Hepatitis A: Inactivated Hepatitis A Vaccine; Combination Vaccines
2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis); DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)
3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine; Booster Dosage Vaccines
4) By Typhoid: Inactivated Typhoid Vaccine; Live Attenuated Typhoid Vaccine
5) By Hepatitis B: Recombinant Hepatitis B Vaccine; Combination Vaccines
6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine; Measles And Rubella (MR) Vaccine
7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP); Rabies Post-exposure Prophylaxis (PEP)
8) By Meningococcal: Meningococcal Conjugate Vaccine; Meningococcal B Vaccine
9) By Other Diseases: Japanese Encephalitis; Cholera; Influenza; Other Emerging Travel Vaccines
Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Sanofi SA; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25360

1. Executive Summary

2. Travel Vaccines Market Characteristics

3. Travel Vaccines Market Trends And Strategies

4. Travel Vaccines Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Travel Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Travel Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Travel Vaccines Market Growth Rate Analysis
5.4. Global Travel Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Travel Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Travel Vaccines Total Addressable Market (TAM)

6. Travel Vaccines Market Segmentation

6.1. Global Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatitis A
Diphtheria, Pertussis, And Tetanus (DPT)
Yellow Fever
Typhoid
Hepatitis B
Measles And Mumps
Rabies
Meningococcal
Other Diseases
6.2. Global Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mono Vaccines
Combination Vaccines
6.3. Global Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Booking
In-Person Booking
6.4. Global Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Domestic Travel
Outbound Travel
6.5. Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis A, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Hepatitis A Vaccine
Combination Vaccines
6.6. Global Travel Vaccines Market, Sub-Segmentation Of Diphtheria, Pertussis, And Tetanus (DPT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Hepatitis A Vaccine
Combination Vaccines
6.7. Global Travel Vaccines Market, Sub-Segmentation Of Yellow Fever, By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Yellow Fever Vaccine
Booster Dosage Vaccines
6.8. Global Travel Vaccines Market, Sub-Segmentation Of Typhoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Typhoid Vaccine
Live Attenuated Typhoid Vaccine
6.9. Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Hepatitis B Vaccine
Combination Vaccines
6.10. Global Travel Vaccines Market, Sub-Segmentation Of Measles And Mumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Measles, Mumps, And Rubella (MMR) Vaccine
Measles And Rubella (MR) Vaccine
6.11. Global Travel Vaccines Market, Sub-Segmentation Of Rabies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rabies Pre-exposure Prophylaxis (PrEP)
Rabies Post-exposure Prophylaxis (PEP)
6.12. Global Travel Vaccines Market, Sub-Segmentation Of Meningococcal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Meningococcal Conjugate Vaccine
Meningococcal B Vaccine
6.13. Global Travel Vaccines Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Japanese Encephalitis
Cholera
Influenza
Other Emerging Travel Vaccines

7. Travel Vaccines Market Regional And Country Analysis

7.1. Global Travel Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Travel Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Travel Vaccines Market

8.1. Asia-Pacific Travel Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Travel Vaccines Market

9.1. China Travel Vaccines Market Overview
9.2. China Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Travel Vaccines Market

10.1. India Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Travel Vaccines Market

11.1. Japan Travel Vaccines Market Overview
11.2. Japan Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Travel Vaccines Market

12.1. Australia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Travel Vaccines Market

13.1. Indonesia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Travel Vaccines Market

14.1. South Korea Travel Vaccines Market Overview
14.2. South Korea Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Travel Vaccines Market

15.1. Western Europe Travel Vaccines Market Overview
15.2. Western Europe Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Travel Vaccines Market

16.1. UK Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Travel Vaccines Market

17.1. Germany Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Travel Vaccines Market

18.1. France Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Travel Vaccines Market

19.1. Italy Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Travel Vaccines Market

20.1. Spain Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Travel Vaccines Market

21.1. Eastern Europe Travel Vaccines Market Overview
21.2. Eastern Europe Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Travel Vaccines Market

22.1. Russia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Travel Vaccines Market

23.1. North America Travel Vaccines Market Overview
23.2. North America Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Travel Vaccines Market

24.1. USA Travel Vaccines Market Overview
24.2. USA Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Travel Vaccines Market

25.1. Canada Travel Vaccines Market Overview
25.2. Canada Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Travel Vaccines Market

26.1. South America Travel Vaccines Market Overview
26.2. South America Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Travel Vaccines Market

27.1. Brazil Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Travel Vaccines Market

28.1. Middle East Travel Vaccines Market Overview
28.2. Middle East Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Travel Vaccines Market

29.1. Africa Travel Vaccines Market Overview
29.2. Africa Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Travel Vaccines Market Competitive Landscape And Company Profiles

30.1. Travel Vaccines Market Competitive Landscape
30.2. Travel Vaccines Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Travel Vaccines Market Other Major And Innovative Companies

31.1. Biological E. Limited
31.2. Takeda Pharmaceutical Company Limited
31.3. Novavax Inc.
31.4. Emergent BioSolutions UK
31.5. Serum Institute of India Pvt. Ltd.
31.6. Dynavax Technologies
31.7. Bavarian Nordic A/S
31.8. Valneva SE
31.9. Panacea Biotec
31.10. Vabiotech
31.11. Inovio Pharmaceuticals
31.12. Bharat Biotech International Limited
31.13. Altimmune Inc.
31.14. Bio Farma
31.15. Vaxart Inc.

32. Global Travel Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Travel Vaccines Market

34. Recent Developments In The Travel Vaccines Market

35. Travel Vaccines Market High Potential Countries, Segments and Strategies

35.1 Travel Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Travel Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Travel Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer